Journal article
Postpartum body weight and cardiometabolic biomarker trajectories in women with gestational diabetes: a population‐based matched cohort study
- Abstract:
-
Aims:
To compare postpartum trajectories in body weight and cardiometabolic biomarkers between women with and without GDM, and to explore the moderating effect of progression to type 2 diabetes (T2DM).
Materials and Methods:
We used electronic primary care healthcare records and linked hospital episode records of women who gave birth between 2001 and 2021. Each woman with GDM was matched to four women without GDM based on age at delivery and delivery date (±3 months). We fitted mixed‐effects multivariate linear models to map biomarker trajectories and extracted coefficients and 95% confidence intervals (CIs) for each year postpartum.
Results:
A total of 43 572 women diagnosed with GDM were matched with 174 288 women without GDM in pregnancy. Across the 15‐year follow‐up, women with GDM weighed more (difference of 5.5 kg [95% CI: 5.3 to 5.7]), had higher HbA1c concentrations (4.4 mmol/mol [95% CI: 4.3 to 4.5]), systolic and diastolic blood pressure (2.6 mmHg [95% CI: 2.4 to 2.7] and 1.7 mmHg [1.6 to 1.8] higher, respectively), and low‐density lipoprotein cholesterol (0.08 [95% CI: 0.06 to 0.10]). However, biomarkers increased at a slower rate during the follow‐up period among women with GDM, except for HbA1c (increase of 9.3 mmol/mol [95% CI: 8.8 to 9.7] and 2.3 mmol/mol [95% CI: 1.9 to 2.6] in the GDM and non‐GDM groups, respectively). Future Progression to type 2 diabetes moderated biomarker trajectories.
Conclusion:
Differences in biomarker trajectories in the early postpartum present an opportunity for early risk stratification and targeted prevention among women with previous GDM.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 3.9MB, Terms of use)
-
- Publisher copy:
- 10.1111/dom.70994
Authors
+ Ministerio de Ciencia, Tecnología e Innovación
More from this funder
- Funder identifier:
- https://ror.org/03fd5ne08
- Grant:
- RYC2020-028818-I
+ NIHR Oxford Musculoskeletal Biomedical Research Centre
More from this funder
- Funder identifier:
- https://ror.org/00aps1a34
- Grant:
- NIHR209636
- Publisher:
- Wiley
- Journal:
- Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics More from this journal
- Publication date:
- 2026-06-22
- Acceptance date:
- 2026-06-03
- DOI:
- EISSN:
-
1463-1326
- ISSN:
-
1462-8902
- Language:
-
English
- Keywords:
- Pubs id:
-
2436956
- Local pid:
-
pubs:2436956
- Deposit date:
-
2026-06-23
- ARK identifier:
Terms of use
- Copyright holder:
- Abdulsalam et al.
- Copyright date:
- 2026
- Rights statement:
- © 2026 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record